We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The report presents a review of etomidate and structurally related compounds and subsequent recommendations regarding their classification and scheduling.
ACMD Chair: Prof Owen Bowden-Jones NPS Committee Secretary: Yetunde…
1. Introduction Etomidate is a drug that has sedative effects and is used…
Sarah Jones MP Minister of State for Policing and Crime 2 Marsham Street…
This report considers the use, harms and control of carisoprodol, a muscle relaxant previously prescribed in the UK to treat muscle spasms.
1. Introduction 1.1. Carisoprodol is an orally active centrally acting…
Two leading experts have been appointed as members of the Advisory Council on the Misuse of Drugs.
Occupations, career history and interests of the members of the Advisory Council on the Misuse of Drugs (ACMD).
Details of the council's committees and latest meeting minutes.
Biographies of members of the Advisory Council on the Misuse of Drugs.
Following a 2025 government commission, the ACMD has carried out a review of the use and harms of ketamine.
The Advisory Council on the Misuse of Drugs (ACMD) has today (28 January 2026) published its updated harms assessment of ketamine.
Review of the evidence on the use and harms of xylazine, medetomidine and detomidine.
An overview of work carried out by the Advisory Council on the Misuse of Drugs (ACMD) from January 2023 to December 2025.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).